Gore Tex Implants in the Treatment of Atrophic Rhinitis (RA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00832403|
Recruitment Status : Suspended (lack of new patients)
First Posted : January 30, 2009
Last Update Posted : January 30, 2009
This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.
The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.
All patients have improved after the procedure.
|Condition or disease||Intervention/treatment|
|Atrophic Rhinitis||Other: implants of polytetrafluoroethylene in tha nasal fossa|
|Study Type :||Observational|
|Actual Enrollment :||5 participants|
|Official Title:||Gore Tex Implants in the Treatment of Atrophic Rhinitis|
|Study Start Date :||November 2006|
|Primary Completion Date :||February 2008|
Other: implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa
- improvement of fetid crusts and atrophy of the mucous bone covering [ Time Frame: after surgery recovery ]
- lack of side effects such as infection [ Time Frame: after the treatment ]